223 related articles for article (PubMed ID: 2509416)
1. The postantibiotic effect of meropenem and imipenem on selected bacteria.
Nadler HL; Pitkin DH; Sheikh W
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():225-31. PubMed ID: 2509416
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of meropenem and imipenem against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa.
Kuti JL; Florea NR; Nightingale CH; Nicolau DP
Pharmacotherapy; 2004 Jan; 24(1):8-15. PubMed ID: 14740783
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the in vitro postantibiotic effect of meropenem and imipenem versus selected enterobacteriaceae and other pathogens.
Nadler HL; Sheikh W
Diagn Microbiol Infect Dis; 1993 Jul; 17(1):71-3. PubMed ID: 8359011
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy.
Schito GC; Sanna A; Chezzi C; Ravizzola G; Leone F; Molinari G; Menozzi MG; Pirali F
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():57-72. PubMed ID: 2681128
[TBL] [Abstract][Full Text] [Related]
5. In vitro postantibiotic effects of tomopenem (CS-023) against Staphylococcus aureus and Pseudomonas aeruginosa.
Tomozawa T; Sugihara C; Kakuta M; Sugihara K; Koga T
J Med Microbiol; 2010 Apr; 59(Pt 4):438-441. PubMed ID: 20093378
[TBL] [Abstract][Full Text] [Related]
6. [In vitro antibacterial activities of carbapenems against clinical isolates].
Murase M
Jpn J Antibiot; 1999 Nov; 52(11):667-79. PubMed ID: 10659443
[TBL] [Abstract][Full Text] [Related]
7. [Bactericidal activity and capacity for selection of mutants resistant to imipenmen and meropenem in strains of Proteus, Morganella and Providencia].
Villar HE; Longo L; Arena MF; Laurino G; Hoffman M
Enferm Infecc Microbiol Clin; 1998; 16(6):261-4. PubMed ID: 9763741
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of meropenem against clinical isolates obtained in Canada.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():47-55. PubMed ID: 2808216
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.
Bauernfeind A; Jungwirth R; Schweighart S
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():73-84. PubMed ID: 2509418
[TBL] [Abstract][Full Text] [Related]
10. In-vitro interactions of DX-8739, a new carbapenem, meropenem and imipenem with amikacin against multiresistant Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
J Antimicrob Chemother; 1996 Aug; 38(2):287-91. PubMed ID: 8877544
[TBL] [Abstract][Full Text] [Related]
11. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
Martínez-Beltrán J; Calderón C; Sierra MP; Alvarez M; Cantón R
Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of BMS-181139, a new carbapenem with potent antipseudomonal activity.
Kessler RE; Fung-Tomc J; Kolek B; Minassian B; Huczko E; Gradelski E; Bonner DP
Antimicrob Agents Chemother; 1995 Feb; 39(2):380-5. PubMed ID: 7726502
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal activity of meropenem and interactions with other antibiotics.
Ferrara A; Grassi G; Grassi FA; Piccioni PD; Gialdroni Grassi G
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():239-50. PubMed ID: 2808210
[TBL] [Abstract][Full Text] [Related]
14. Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem.
Odenholt-Tornqvist I
J Antimicrob Chemother; 1993 Jun; 31(6):881-92. PubMed ID: 8360126
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic effects of meropenem on gram-negative bacteria.
Hanberger H; Svensson E; Nilsson LE; Nilsson M
Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):383-90. PubMed ID: 7556226
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci.
Kitzis MD; Acar JF; Gutmann L
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():125-32. PubMed ID: 2808204
[TBL] [Abstract][Full Text] [Related]
17. Activity of meropenem against imipenem-resistant bacteria and selection in vitro of carbapenem-resistant Enterobacteriaceae.
Piddock LJ; Turner HL
Eur J Clin Microbiol Infect Dis; 1992 Dec; 11(12):1186-91. PubMed ID: 1291320
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal activity of meropenem against Pseudomonas aeruginosa.
Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():169-74. PubMed ID: 2509414
[TBL] [Abstract][Full Text] [Related]
19. In vitro postantibiotic effect of imipenem and enoxacin alone and in combination against Pseudomonas aeruginosa.
Hostacká A
Pharmazie; 1997 Jul; 52(7):544-6. PubMed ID: 9266592
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of biapenem, a new carbapenem antibiotic.
Clarke AM; Zemcov SJ
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):377-84. PubMed ID: 8354306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
